FDAnews
www.fdanews.com/articles/70794-sequoia-pharmaceuticals-secures-funding-to-test-aids-drug

Sequoia Pharmaceuticals Secures Funding to Test AIDS Drug

April 6, 2005

Sequoia Pharmaceuticals, a pharmaceutical company focused on discovering novel drugs to combat drug-resistant viral infections, today announced that it closed on a $22 million Series B round of financing. The investment syndicate was led by Health Care Ventures of Cambridge, MA, and includes Sofinnova Partners of Paris; Aberdare Ventures of San Francisco; and the Wellcome Trust of London. The financing is expected to fund early stage clinical trials of the Company's novel drug designed to combat wild-type- and multi-drug-resistant strains of HIV, and to continue two additional drug discovery and development programs.

BigNews Network (http://feeds.bignewsnetwork.com/redir.php?jid=6882b319f00c815e&cat=6dcd932030878143)